Literature DB >> 33564566

Telemedicine in the Wake of the COVID-19 Pandemic: Increasing Access to Surgical Care.

Paige K Dekker1, Priya Bhardwaj2, Tanvee Singh2, Jenna C Bekeny2, Kevin G Kim1, John S Steinberg3, Karen K Evans1, David H Song1, Christopher E Attinger1, Kenneth L Fan1,4.   

Abstract

The COVID-19 pandemic has brought seismic shifts in healthcare delivery. The objective of this study was to examine the impact of telemedicine in the disadvantaged population.
METHODS: All consecutive patients with outpatient appointments amongst 5 providers in the Plastic and Reconstructive Surgery Department between March 2, 2020, and April 10, 2020, were retrospectively reviewed. Appointment and patient characteristics collected include visit modality, reason for visit, new or established patient, history of recorded procedure, age, sex, race, insurance provider, urban/rural designation of residence, Social Vulnerability Index, and income. The primary outcome of interest was whether or not a patient missed their appointment (show versus no-show).
RESULTS: During the study period, there were a total of 784 patient appointments. Before the COVID-19 pandemic, patients with a higher Social Vulnerability Index were more likely to have a no-show appointment (0.49 versus 0.39, P = 0.007). Multivariate regression modeling showed that every 0.1 increase in Social Vulnerability Index results in 1.32 greater odds of loss to follow-up (P = 0.045). These associations no longer held true after the lockdown.
CONCLUSIONS: This study indicates a reduction in disparity and an increase in access following the dramatically increased use of telemedicine in the wake of the COVID-19 pandemic. Although drawbacks to telemedicine exist and remain to be addressed, the vast majority of literature points to an overwhelming benefit-both for patient experience and outcomes-of utilizing telemedicine. Future studies should focus on improving access, reducing technological barriers, and policy reform to improve the spread of telemedicine.
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.

Entities:  

Year:  2020        PMID: 33564566      PMCID: PMC7858711          DOI: 10.1097/GOX.0000000000003228

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


INTRODUCTION

The COVID-19 pandemic has resulted in unparalleled shifts and strain in care delivery. Outside of natural disasters, implementation of telehealth and telemedicine has progressed at a slow and fragmented pace.[1] Growth in usage between 2005 and 2017 was focused primarily amongst psychiatrists and primary care physicians and utilized by younger patients in urban environments.[2] In an effort to curtail the spread of COVID-19, governments and the medical community have responded with a broad shift away from hospital-based care, with cancelled elective surgery and rapid deployment of telemedicine. To mitigate concerns of privacy violations and to broaden use, on March 17, 2020, the Office of Civil Rights at the Department of Health and Human Services issued a statement waiving potential penalties against healthcare providers for Health Insurance Portability and Accountability Act (HIPAA) violations.[3] In particular, clear language states that these penalty waivers will apply to “widely available communication platforms, such as FaceTime or Skype, when used in good faith for any telehealth treatment or diagnostic period, regardless of whether the telehealth service is directly related to COVID-19.” As the pandemic evolved, it also became apparent that a disproportionate number of cases have affected the elderly, men, and those with comorbidities such as hypertension, diabetes, obesity, cardiovascular disease, and minority populations,[4-7] mirroring the H1N1 experience in 2009.[8,9] Although there is a need to limit exposure, reconstruction patients (particularly those with active wounds) require a frequent follow-up to prevent wound recurrence and amputation. Delays in such follow-ups lead to prolonged healing times and increased risk of amputation.[10,11] Furthermore, several studies have identified worse disease presentation and higher rates of amputation in minority and disadvantaged populations.[12-15] In a systematic review of studies examining barriers in telehealth adoption, Kruse et al identified that the top 3 barriers for patients were age, level of education, and computer literacy.[16] These underlying challenges, coupled with the rapid deployment of telehealth, call into question the effectiveness of technological modalities in caring for disadvantaged patients. The strategies to limit contact during the current COVID-19 pandemic may be in place for 18 months or longer until widespread vaccination is seen.[17] Therefore, it is necessary to ensure equitable distribution of resources and attention to the vulnerable. The objective of this study was to examine how the acute expansion of telemedicine during the COVID-19 pandemic may have impacted access to surgical care in the disadvantaged population. In particular, we sought to investigate whether patient demographics were associated with missed in-person appointments. Special attention was given to the Social Vulnerability Index (SVI), which was created and is maintained by the Geospatial Research, Analysis, and Services Program (GRASP) at the Center for Disease Control and Prevention (CDC). We hypothesize that in the wake of the COVID-19 pandemic, the rapid deployment of telemedicine enhanced access to surgical care for more vulnerable populations.

METHODS

All consecutive patients with outpatient appointments among 5 providers in the Plastic and Reconstructive Surgery Department between March 2, 2020, and April 10, 2020, were retrospectively reviewed. These providers were selected as (1) the 5 highest volume providers and (2) those with the highest percentage of patient visits at our hospital-based practice and not at affiliate hospitals or off-site outpatient clinics. In the District of Columbia, a public emergency was announced on March 11, 2020, and stay-at-home orders were enforced beginning on April 1, 2020. Our system began a multi-phase expansion of its telemedicine platform beginning on March 23, 2020. This date served as an anchor for data collection to capture patients seen by our service before and after the expansion of telemedicine in our system. Patient groups were primarily wound care, general reconstruction, and breast reconstruction.

Data Collection

Data on the following domains were collected from the electronic health record. Appointment characteristics included visit modality (in-person, phone appointment, and video appointment), reason for visit, new or established patient, and history of recorded procedure. Patient characteristics included demographics such as age, sex, race, insurance provider, urban/rural designation of the location of residence, SVI, and median income by location of residence. The primary outcome of interest was whether or not patients missed their appointment (show versus no-show). For city/suburb/town/rural designation and median income by area of residence, Zone Improvement Program (ZIP) Codes were converted to Zip Code Tabulation Areas (ZCTA), as used by the Census Bureau. ZIP codes are designed to represent linear mail delivery routes, whereas ZCTAs represent more generalized spatial codes that are assigned by census block. For locality designation, the National Center for Education Statistics 2019 data were utilized.[18] For median income by ZCTA, the S1901 table from the American Community Survey in 2019 was obtained.[19] The overall SVI is derived from census tract-level data, which account for increased granularity of neighborhoods. This is especially important, given the heterogeneous nature of communities in the District of Columbia and its surrounding areas. Census tracts were obtained from the Federal Financial Institutions Examination Council geocoding system, which is used by financial institutions to report information on mortgages as well as business and farm loans.[19,20] For addresses that were developed after the census was performed, census tract information was extrapolated based on the longitude and latitude of the address derived from the Google Maps API. The SVI refers to the socioeconomic and demographic characteristics of a community that impact its resilience when faced with external stressors to human health, including disease outbreaks. The SVI ranks census tracts based on 15 social factors, grouped into 4 themes (Socioeconomic Status, Household Composition and Disability, Minority Status and Language, and Housing Type and Transportation), for an overall SVI score.[21] For this study, the overall SVI score was used. A pre-published study suggests that the SVI is associated with higher COVID-19 case fatality.[22]

Definitions and Exclusion Criteria

Patients from outside the District of Columbia, Maryland, and Virginia regions were eliminated from analysis. A “no-show” was defined as any appointment that a patient did not attend and was both (1) not intentionally rescheduled before the appointment date and (2) the patient was not hospitalized other reasons. Insurances were categorized as commercial (HMO/PPO), Medicaid, or Medicare. Self-pay and other insurances were excluded due to small numbers. Ethnicity was categorized as White, Black, or Other due to the low representation of American Indians, Asians, and Pacific Islanders in our region.[23]

Statistical Analysis

The statistical analysis was broadly separated into pre-lockdown and post-lockdown to determine the differences between no-show characteristics. Continuous variables were described by means and SDs. The student t-test was used to examine statistically significant differences between continuous variables when normality assumption was satisfied; the Wilcoxon rank sum test was used when normality assumption was not satisfied. Categorical variables were described by frequencies and percentages. Chi-square and Fisher exact tests (n < 10) were used as appropriate to examine statistically significant differences between categorical variables. To test for spatial autocorrelation and clustering of no-show appointments, Moran’s I test for autocorrelation was used.[24,25] Two multivariate models before and after the COVID-19 lockdown were constructed with variables selected based on the purposeful selection method, as described by Hosmer and Lemeshow.[26-28] Multicollinearity was tested to assess the effects of certain variables on others within each model.[29] Statistical analysis was performed using STATA, v.15 (StataCorp, College Station, Tex.), with significance defined as P < 0.05.

RESULTS

Table 1 describes the characteristics of the study cohort. During the study period, there were 506 patients seen before the lockdown and 278 patients were seen after, which amounts to a 45% decline in overall visits. Before the lockdown, the composition of our patient population was overrepresented by the elderly and Medicare (42.69% versus 8%) and underrepresented by Medicaid (15.02% versus 28%) when compared with the DC area population.[23] Moreover, the average median income is higher for the study group compared with that in the DC area ($99,002 versus $82,372). However, racial composition is similar. The majority of the cohort have active wounds. There is no difference in the SVI or median income by ZCTA before and after COVID-19. Video and phone visits went from comprising 0.59% and 0.79% of visits, respectively, to representing 26.26 and 18.35% of visits, whereas outpatient visits declined 43.2% (P < 0.001). New patient visits declined from 23.52% to 9.35% (P < 0.001). There was a decrease in patients seen without a history of surgery from 48.81% to 31.65% (P < 0.001). There were no significant changes in the number of no-show appointments.
Table 1.

Sample Characteristics Pre-COVID and Post-COVID Lockdown

Pre-lockdownPost-lockdownP
No. patients506278
Age59.40 ± 15.6761.04 ± 14.760.154
Gender0.315
 Men24147.63%12243.88%
 Women26552.37%15656.12%
Ethnicity0.086
 White21041.50%11541.37%
 Black23145.65%14150.72%
 Other6512.85%227.91%
Insurance type0.669
 Commercial21442.29%11441.01%
 Medicaid7615.02%3713.31%
 Medicare21642.69%12745.68%
Locality0.353
 City23245.85%11441.01%
 Suburb19338.14%11139.93%
 Rural8116.01%5319.06%
History of wounds0.713
 Yes40479.84%22580.94%
 No10220.16%5319.06%
SVI0.40 ± 0.290.41 ± 0.290.559
Median income by ZCTA$98,881.18 ± $38,228.90$99,222.17 ± $41,316.300.908
Visit type<0.001
 In-person49998.62%15455.40%
 Video30.59%7326.26%
 Phone40.79%5118.35%
Patient status<0.001
 New patient11923.52%269.35%
 Established patient38776.48%25290.65%
History of surgery<0.001
 Yes25951.19%19068.35%
 No24748.81%8831.65%
No-show0.544
 Yes6512.85%4014.39%
 No44187.15%23885.61%

Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes the highest vulnerability.

Sample Characteristics Pre-COVID and Post-COVID Lockdown Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes the highest vulnerability. Tables 2 and 3 demonstrate characteristics of patients who showed or missed their appointment before and after the lockdown, respectively. Before the lockdown, younger (P = 0.006), male (P = 0.032), and established (P = 0.035) patients with Medicaid (P = 0.027) were more likely to have a no-show appointment. Patients with a higher SVI were also more likely to have a no-show appointment (0.49 versus 0.39, P = 0.007). After the lockdown, neither age, nor sex, nor established status, nor insurance, nor SVI were any longer significant.
Table 2.

Demographic Characteristics of No-show Appointments before Lockdown

Pre-lockdown
No-show AppointmentYesNoP
No. patients65441
Age54.38 ± 15.4360.14 ± 15.580.006
Gender0.032
 Men3916.18%20283.82%
 Women269.81%23990.19%
Ethnicity0.075
 White199.05%19190.95%
 Black3515.15%19684.85%
 Other1116.92%5483.08%
Insurance type0.027
 Commercial2411.21%19088.79%
 Medicaid1722.37%5977.63%
 Medicare2411.11%19288.89%
Locality0.968
 City2912.50%20387.50%
 Suburb2512.95%16887.05%
 Rural1113.58%7086.42%
SVI0.49 ± 0.310.39 ± 0.280.007
Median income by ZCTA$98,920.51 ± $34,886.35$98,875.39 ± $38,733.930.993
Visit type0.620
 In-person6412.83%43587.17%
 Video00%3100%
 Phone125%375%
Patient status0.035
 New patients4311.11%34488.89%
 Established patients2218.49%9781.51%
History of surgery0.006
 Yes238.88%23691.12%
 No4217.00%20583.00%
History of wounds0.174
 Yes5613.86%34886.14%
 No98.82%9391.18%

Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes the highest vulnerability.

Table 3.

Demographic Characteristics of No-show Appointments after Lockdown

Post-lockdown
No-show AppointmentsYesNoP
No. patients40238
Age63.86 ± 14.1160.56 ± 14.840.192
Gender0.235
 Men2117.21%10182.79%
 Women1912.18%13787.82%
Ethnicity0.527
 White1412.17%10187.83%
 Black2417.02%11782.98%
 Other29.09%2090.91%
Insurance type0.243
 Commercial1210.53%10289.47%
 Medicaid513.51%3286.49%
 Medicare2318.11%10481.89%
Locality0.746
 City1815.79%9684.21%
 Suburb1614.41%9585.59%
 Rural611.32%4788.68%
SVI0.40 ± 0.310.42 ± 0.290.780
Median income by ZCTA$101,590.60 ± $45,629.108$98,824.11 ± $40,637.7670.696
Visit type0.050
 In-person2918.83%12581.17%
 Video810.96%6589.04%
 Phone35.88%4894.12%
Patient status0.307
 New patients27.69%2492.31%
 Established patients3815.08%21484.92%
History of surgery0.111
 Yes2312.11%16787.89%
 No1719.32%7180.68%
History of wounds0.044
 Yes3716.44%18883.56%
 No35.66%5094.34%

Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability and that of “1” denotes the highest vulnerability.

Demographic Characteristics of No-show Appointments before Lockdown Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes the highest vulnerability. Demographic Characteristics of No-show Appointments after Lockdown Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability and that of “1” denotes the highest vulnerability. Table 4 examines the SVI characteristics by visit type. Before the lockdown, the SVI of patients with a no-show in-person appointment was 0.50 compared with 0.39 (P = 0.007) for patients who showed for their in-person appointments. There was no difference in SVI after the lockdown between patients who had shown for their appointment and those who did not. Figure 1 demonstrates that the SVI of new patients (0.44 versus 0.45) and established patients (0.39 versus 0.41) increased after the lockdown versus before the lockdown, although this association was not statistically significant (P = 0.382).
Table 4.

SVI by Visit Type before and after Lockdown

Pre-lockdownPost-lockdown
No-ShowYesNoPYesNoP
 In-person0.50 ± 0.300.39 ± 0.280.0070.42 ± 0.320.41 ± 0.300.818
 VideoN/A0.29 ± 0.180.37 ± 0.270.41 ± 0.29
 Phone0.17 ± 00.46 ± 0.390.32 ± 0.280.44 ± 0.29

An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes highest vulnerability.

Values in bold denote significant p-values (P < 0.05).

Fig. 1.

Mean SVI for new and established patients, before and after COVID-19 lockdown.

SVI by Visit Type before and after Lockdown An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes highest vulnerability. Values in bold denote significant p-values (P < 0.05). Mean SVI for new and established patients, before and after COVID-19 lockdown. Table 5 reports the findings of the 2 multivariate regression models for no-show appointments before and after lockdown. Before lockdown, every year decrease in age resulted in a 2% increased chance in missing their appointment (OR = 0.98, P = 0.01). Similarly, male patients had a 1.94 increased odds of missing their appointment (P = 0.02). For socially vulnerable patients, every 0.1 increase in SVI results in 1.32 greater odds of loss to follow-up (P = 0.045). These associations no longer held true after the lockdown. In-person appointments were 3.72 times more likely to be a no-show compared with phone appointments (P = 0.039). There was no clustering of no-show appointments before (P = 0.335), after (P = 0.458), or amongst all patients (P = 0.387).
Table 5.

Multivariate Regression Models: Impact of Telemedicine before and after Lockdown on No-show Appointments

Pre-lockdownPost-lockdown
Odds RatioConfidence IntervalPOdds RatioConfidence IntervalP
Age0.980.96, 0.990.011.020.99, 1.040.21
Gender
 Men1.941.11, 3.370.021.340.67, 2.690.41
 WomenReferenceReference
Ethnicity
 WhiteReferenceReference
 Black1.260.64, 2.460.501.720.75, 3.940.20
 Other1.500.65, 3.470.350.850.16, 4.330.85
Locality
 UrbanReferenceReference
 Suburb1.230.67, 2.250.510.890.41, 1.940.76
 Rural1.300.59, 2.830.510.770.27, 0.180.63
Patient status
 New patient1.640.91, 2.950.0970.500.11, 0.320.38
 Established  patientReferenceReference
SVI2.851.02, 7.940.0450.590.15, 2.380.46
Visit type
 In-personN/A3.721.06, 13.00.039
 Video1.860.46, 7.540.382
 PhoneReference
Multivariate Regression Models: Impact of Telemedicine before and after Lockdown on No-show Appointments

DISCUSSION

Telemedicine has seen rapid expansion in the wake of the recent pandemic. Telehealth refers to the broad use of health-related digital services, including monitoring wearables or patient education videos.[30] Telemedicine refers to remote diagnosis and treatment using digital technology. Before COVID-19, telemedicine’s expansion was curtailed due to several factors relating to reimbursement, licensure, and infrastructure. Medicare narrowly defined applications to select rural populations. Payments under Medicaid were defined by individual state legislation. Only 10 states (Arkansas, Delaware, Georgia, Hawaii, Kentucky, Minnesota, Missouri, New Mexico, Utah, and Virginia) have laws on true payment parity between telemedicine and in-person visits, whereas 16 states have a provision on the payment structure.[31,32] When 104 health care organizations were surveyed, 50% of them reported reimbursement as a significant cause of limitation to deployment.[30] There were also limitations in cross-state licensure, limiting providers’ ability to utilize telemedicine to conduct visits with patients outside of their own state.[33] As a result of these obstacles to licensure and payment, there was little investment in infrastructure by health providers and organizations alike. On March 6, 2020, Medicare expanded telehealth services as a temporary and emergency effort under 1135 waiver authority and the Coronavirus Preparedness and Response Supplemental Appropriations Act. Telehealth services were previously limited to designated rural areas.[34] In these provisions, Medicare telehealth visits for new and established patients are considered the same as in-person visits and are reimbursed at the same rate in all areas of the country for all settings.[34] Furthermore, most states have relaxed licensure requirements for physicians with out-of-state licenses who wish to practice telehealth.[35] Broadly speaking, the Centers for Medicaid and Medicare Services categorizes virtual services into 3 main types: televisits, virtual check-ins, and e-visits. Medicare televisits involve interactive audio and telecommunication systems with healthcare providers for new and established patients. Virtual check-ins are 5- to 10-minute communications conducted via telephone or other communication modalities (secure text messaging and email). These are scheduled in response to specific patient concerns that are not related to a medical visit within the previous 7 days or do not result in a visit within the following 24 hours. Although virtual check-ins are generally initiated by patients, providers can educate patients on the availability of these services. Similarly, e-visits are communications that are initiated by established patients through an online portal and are intended to save patients’ trips to physician offices. The rapid expansion of telemedicine has created a natural experiment on access to care in the vulnerable population. Access to care, as defined by Shi and Singh, “can be defined as the ability to obtain needed, affordable, convenient, acceptable, and effective personal health services in a timely manner.”[36] Prior examination of the benefits of telemedicine has demonstrated improvements in access to care for rural patients across multiple healthcare specialties.[37,38] Recent research also indicates that telemedicine increases access to care for patients with acute illness in socially disadvantaged populations, which more appropriately distributes healthcare resources.[39] However, few studies examine the impact of telemedicine in the surgical subspecialties, especially in the face of the national pandemic. Despite general improvements in healthcare in America, avoidable access issues are pervasive amongst disparate populations.[40] In the previous office-based model, patients of higher SVI were more likely to miss their appointments. The results of this study demonstrate that expansion of telemedicine in the COVID-19 pandemic resulted in improved reach of new and established surgical patients. Anecdotally, patients have been very satisfied with the new format. People who were unable to take “off from work” or arrange childcare, or have difficulties in mobility and arranging transportation are now being seen at greater rates. These finding are in line with a study on the CVS MinuteClinics telehealth program.[41] In these visits, physician and patients communicate through 2-way audio and video, and diagnoses are made through history and physicals, and via digital audioscopes and otoscopes. Amongst surveyed patients, 94% reported being very satisfied with the experience, with over half citing the absence of waiting time as their primary motivator for use. Similar high levels of satisfaction were achieved in underserved, rural plastic surgery patients in Vermont and New Hampshire.[42] Telemedicine has also proved to have benefits on patient outcomes. One study examining utilization of telemedicine by a wound specialist in conjunction with home health nurses found improved rates of healing, faster healing time, decreased number of home health visits, and fewer hospitalizations for wound complications after telehealth implementation.[43] A high level of correlation between in-person and photograph evaluation for the diagnosis and treatment of wounds has been confirmed in the literature.[44,45] Systematic review indicates telemedicine increases efficiency, decreases cost, and increases access of microsurgical monitoring, burn evaluation, and cleft lip/palate consultations.[42,46] Despite the potential benefits in patient experience and outcomes that may be offered by telemedicine, there are also challenges that must be addressed. Although not statistically significant, we have found that elderly patients and those with limited access and understanding of technology still have difficulty accessing our established online portal. Creative solutions, such as use of FaceTime, the patient’s video conferencing application of choice, or text message, have had to be employed in many instances. It will be critical to establish easy-to-use, HIPAA-compliant technologies to scale. Furthermore, there are limitations in assessing surgical incisions and wounds with current telemedicine platforms. Picture and video quality can be poor, especially if online networks are strained. Patients have to be coached to show the involved body part for context. Commonly, we receive pictures of areas of interest they deem important. This is particularly germane in new patient consults, as a patient–provider relationship is established with transmission of the image.[45] The provider assumes legal responsibility, without having met the patient. In the absence of a home health aide, we have to rely on patient’s assessment of warmth, which can be limited. This is particularly salient in the wound population, where decline in warmth can indicate a threatened extremity. Other issues identified in the literature include misdiagnosis, inefficient use of provider time due to technological difficulties, and delays in diagnosis.[45] Limitations of this study include the limited number of providers practicing in an urban, academic setting. Our findings may not be generalizable to different localities, including community or rural environments. Furthermore, outcomes such as complications arising from telemedicine use were not directly examined. It is unknown whether the completed telemedicine visits in more vulnerable patients are equitable from a quality perspective. Future study will require an in-depth evaluation of provider and patient factors, barriers to use, reliability of diagnosis and treatments recommended, patient satisfaction, and the workflow of the telemedicine visit, with a focus on elderly and disadvantaged patients.

CONCLUSIONS

Overall, expansion of telemedicine in the COVID-19 era represents a dramatic and, possibly, permanent shift in the way we practice medicine. The results of this study indicate a disparity reduction and increased access in an urban population. The majority of the literature, despite issues with technology and lack of physical contact, cites overwhelming benefits.[41-47] Future studies should focus on the barriers to use, reliability, patient satisfaction, and workflow in elderly and disadvantaged patients. Sustained meaningful adoption of telemedicine and telehealth will require multi-faceted regulatory flexibility and reform, as seen in the temporary and emergent measures enacted due to the COVID-19 pandemic.[48]
  31 in total

Review 1.  Telemedicine and plastic surgery: a review of its applications, limitations and legal pitfalls.

Authors:  Sonya Gardiner; Tristan L Hartzell
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-12-16       Impact factor: 2.740

Review 2.  Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers.

Authors:  Ronald S Weinstein; Ana Maria Lopez; Bellal A Joseph; Kristine A Erps; Michael Holcomb; Gail P Barker; Elizabeth A Krupinski
Journal:  Am J Med       Date:  2013-10-29       Impact factor: 4.965

3.  Variation in the incidence and proportion of diabetes-related amputations in minorities.

Authors:  L A Lavery; H R Ashry; W van Houtum; J A Pugh; L B Harkless; S Basu
Journal:  Diabetes Care       Date:  1996-01       Impact factor: 19.112

4.  The impact of telemedicine on outcomes of chronic wounds in the home care setting.

Authors:  L Kobza; A Scheurich
Journal:  Ostomy Wound Manage       Date:  2000-10       Impact factor: 2.629

5.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

Authors:  Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

6.  Advancing health equity and access using telemedicine: a geospatial assessment.

Authors:  Saif Khairat; Timothy Haithcoat; Songzi Liu; Tanzila Zaman; Barbara Edson; Robert Gianforcaro; Chi-Ren Shyu
Journal:  J Am Med Inform Assoc       Date:  2019-08-01       Impact factor: 4.497

7.  Innovations in the Plastic Surgery Care Pathway: Using Telemedicine for Clinical Efficiency and Patient Satisfaction.

Authors:  Christopher D Funderburk; Nicole S Batulis; Justin T Zelones; Alec H Fisher; Kimberly L Prock; Nickolay P Markov; Alison E Evans; John F Nigriny
Journal:  Plast Reconstr Surg       Date:  2019-08       Impact factor: 4.730

8.  Racial disparities in exposure, susceptibility, and access to health care in the US H1N1 influenza pandemic.

Authors:  Sandra Crouse Quinn; Supriya Kumar; Vicki S Freimuth; Donald Musa; Nestor Casteneda-Angarita; Kelley Kidwell
Journal:  Am J Public Health       Date:  2010-12-16       Impact factor: 9.308

9.  The reliability of digital imaging in the remote assessment of wounds: defining a standard.

Authors:  Robert X Murphy; Michael A Bain; Thomas E Wasser; Eric Wilson; Walter J Okunski
Journal:  Ann Plast Surg       Date:  2006-04       Impact factor: 1.539

10.  Are Clinicians Contributing to Excess African American COVID-19 Deaths? Unbeknownst to Them, They May Be.

Authors:  Adam J Milam; Debra Furr-Holden; Jennifer Edwards-Johnson; Birgete Webb; John W Patton; Nnayereugo C Ezekwemba; Lekiesha Porter; TomMario Davis; Marius Chukwurah; Antonio J Webb; Kevin Simon; Geden Franck; Joshua Anthony; Gerald Onuoha; Italo M Brown; James T Carson; Brent C Stephens
Journal:  Health Equity       Date:  2020-04-17
View more
  4 in total

1.  The Development of Telemedicine and eHealth in Surgery during the SARS-CoV-2 Pandemic.

Authors:  Anas Taha; Bara Saad; Bassey Enodien; Marta Bachmann; Daniel M Frey; Stephanie Taha-Mehlitz
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

2.  Evaluating the ability of students to learn and utilize a novel telepresence platform, Proximie.

Authors:  Ela Patel; Anya Mascarenhas; Subuhee Ahmed; Daniel Stirt; Isabella Brady; Roshane Perera; Jonathan Noël
Journal:  J Robot Surg       Date:  2021-11-06

3.  The Impact of Telehealth Adoption During COVID-19 Pandemic on Patterns of Pediatric Subspecialty Care Utilization.

Authors:  Eli M Cahan; Jay Maturi; Paige Bailey; Susan Fernandes; Ananta Addala; Sara Kibrom; Jill R Krissberg; Stephanie M Smith; Sejal Shah; Ewen Wang; Olga Saynina; Paul H Wise; Lisa J Chamberlain
Journal:  Acad Pediatr       Date:  2022-03-19       Impact factor: 2.993

4.  Patients' Perceptions and Satisfaction with the Outpatient Telemedicine Clinics during COVID-19 Era in Saudi Arabia: A Cross-Sectional Study.

Authors:  Ashokkumar Thirunavukkarasu; Nasser Hanas Alotaibi; Ahmad Homoud Al-Hazmi; Mohammed Jayed Alenzi; Ziad Mansour Alshaalan; Mohammed Ghazi Alruwaili; Thamer Alshami Marghel Alruwaili; Hassan Alanazi; Turki Hanas Alosaimi
Journal:  Healthcare (Basel)       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.